Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Thérapies Ciblées
Extract
A randomized study of the effect of maintenance therapy with bevacizumab + capecitabine versus bevacizumab alone on progression-free survival in patients with HER2-negative metastatic breast cancer that has not progressed during first-line docetaxel plus bevacizumab therapy.
Scientific Abstract
en cours d'intégration;